FR2499414B1 - Production d'anticorps proteiniques humains - Google Patents

Production d'anticorps proteiniques humains

Info

Publication number
FR2499414B1
FR2499414B1 FR8201862A FR8201862A FR2499414B1 FR 2499414 B1 FR2499414 B1 FR 2499414B1 FR 8201862 A FR8201862 A FR 8201862A FR 8201862 A FR8201862 A FR 8201862A FR 2499414 B1 FR2499414 B1 FR 2499414B1
Authority
FR
France
Prior art keywords
production
human protein
protein antibodies
antibodies
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8201862A
Other languages
English (en)
Other versions
FR2499414A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of FR2499414A1 publication Critical patent/FR2499414A1/fr
Application granted granted Critical
Publication of FR2499414B1 publication Critical patent/FR2499414B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
FR8201862A 1981-02-06 1982-02-05 Production d'anticorps proteiniques humains Expired FR2499414B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56015812A JPS5823847B2 (ja) 1981-02-06 1981-02-06 抗ヒト蛋白質抗体の製造方法

Publications (2)

Publication Number Publication Date
FR2499414A1 FR2499414A1 (fr) 1982-08-13
FR2499414B1 true FR2499414B1 (fr) 1985-10-25

Family

ID=11899249

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8201862A Expired FR2499414B1 (fr) 1981-02-06 1982-02-05 Production d'anticorps proteiniques humains

Country Status (7)

Country Link
US (2) US4474756A (fr)
JP (1) JPS5823847B2 (fr)
KR (1) KR870002162B1 (fr)
CH (1) CH650684A5 (fr)
FR (1) FR2499414B1 (fr)
GB (1) GB2096146B (fr)
IT (1) IT1189215B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
EP0084344A3 (fr) * 1982-01-14 1983-08-03 Asahi Kasei Kogyo Kabushiki Kaisha Anticorps monoclonaux anti-urokinase et leur procédé de préparation
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
US4693891A (en) * 1985-09-09 1987-09-15 Miles Laboratories, Inc. Vaccine for Pseudomonas aeruginosa
US4707543A (en) * 1985-09-17 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
FR2593705B1 (fr) * 1986-02-04 1991-07-26 Lafon Labor Composition pour l'interruption de la grossesse comprenant des anticorps monoclonaux reconnaissant l'hormone chorionique gonadotrope ou un peptide de structure analogue, anticorps monoclonaux, procede de production de ces anticorps, hybridomes et procede d'obtention de ces hybridomes
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
EP0326111A3 (fr) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Dérivés de peptide rendus immunogéniques lors de l'administration d'un alun comme adjuvant
DE3812181A1 (de) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller Arzneimittel, enthaltend natuerliche und/oder chemisch modifizierte mono- oder polysaccharide und deren verwendung
JP2896580B2 (ja) * 1989-08-25 1999-05-31 チッソ株式会社 アミロース―リゾチームハイブリッドと活性化糖およびその製造法
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
DE69222295T2 (de) * 1992-05-26 1998-04-09 Procter & Gamble Pulverförmige pharmazeutische Zusammensetzung
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
WO1996009805A2 (fr) * 1994-09-23 1996-04-04 Zonagen, Inc. Immunostimulation induite par le chitosane
US5980912A (en) * 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US5960824A (en) * 1998-06-01 1999-10-05 Ford Motor Company Scroll compressor having contoured fixed rotation suction control valve
US6280742B1 (en) 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
AU6049099A (en) * 1998-09-17 2000-04-03 Zonagen, Inc. Human chorionic gonadotropin vaccines
US7541159B2 (en) * 2004-04-14 2009-06-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Molecular-specific urokinase antibodies
JP5860480B2 (ja) 2011-01-11 2016-02-16 キャプシュゲル・ベルジウム・エヌ・ヴィ プルランを含む新しい硬カプセル
EP3610028A1 (fr) 2017-04-14 2020-02-19 Capsugel Belgium NV Procédé de fabrication de pullulane
US11576870B2 (en) 2017-04-14 2023-02-14 Capsugel Belgium Nv Pullulan capsules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758425A (fr) * 1969-12-02 1971-04-16 Baxter Laboratories Inc Streptokinase liee chimiquement a une matrice en carbohydrate (
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
FR2244543B1 (fr) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2319379A1 (fr) * 1975-07-29 1977-02-25 All India Inst Medical Scie Vaccin contre la gravidite et procede de sa preparation
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same

Also Published As

Publication number Publication date
FR2499414A1 (fr) 1982-08-13
GB2096146B (en) 1984-08-08
IT8247705A0 (it) 1982-02-02
US4814169A (en) 1989-03-21
GB2096146A (en) 1982-10-13
IT1189215B (it) 1988-01-28
JPS57130922A (en) 1982-08-13
CH650684A5 (fr) 1985-08-15
KR830008685A (ko) 1983-12-14
US4474756A (en) 1984-10-02
KR870002162B1 (ko) 1987-12-14
JPS5823847B2 (ja) 1983-05-18

Similar Documents

Publication Publication Date Title
FR2499414B1 (fr) Production d'anticorps proteiniques humains
FR2490675B1 (fr) Production microbienne d'interferon de fibroplaste humain
FR2522679B1 (fr) Procede pour la production d'anticorps monoclonaux humains
PT80292B (pt) Preparacao de factor viii humano funcional
BE873813R (fr) Preparation d'oligoimides
BE891003A (fr) Production d'anticorps monocloniques humains au moyen d'hydrodomes humains
IT1207589B (it) Composizione di anticorpi monoclonali umani cross-protettivi.
PT80264A (fr) Preparation de derives de l'hydroxy-4-2h-1-benzothiopyran-2-one
FR2495635B1 (fr) Production d'urokinase humaine
FR2579597B1 (fr) Esters d'alceneamidocephalosporines
BE890465A (fr) Prothese d'osselets
FR2510604B1 (fr) Production d'activateur de plasminogene
BE890376R (fr) Preparation d'acetaldehyde
BE893322A (fr) Preparation d'acides carboxyliques
FR2535322B1 (fr) Preparation d'acides aminocyclopentaniques
FR2549726B1 (fr) Facteurs augmentant la formation d'anticorps humains et procede pour leur preparation
IT1192483B (it) Kanamicine 2'-modificate e produzione di queste
BR8807102A (pt) Preparacao de novos adocantes de proteina
FR2587357B1 (fr) Anticorps monoclonaux
BE880941A (fr) Preparation d'acetaldehyde
FR2509815B1 (fr) Accouplement d'arbres
FR2566265B1 (fr) Bague d'extension phallique
LV5036A3 (lv) Preparats "Jodkligol" govju endometritu arstesanai
FR2512675B1 (fr) Hydrolat d'agaricus biosporus et campester
NO941347D0 (no) Fremgangsmåte for fremstilling av et humant monoklonalt antistoff

Legal Events

Date Code Title Description
ST Notification of lapse